Condition | Indicated | Relationship Strength | Studies | Trials |
Aldosteronism [description not available] | 0 | 9.9 | 35 | 2 |
Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. | 0 | 9.9 | 35 | 2 |
Adenoma, Basal Cell [description not available] | 0 | 4.55 | 9 | 0 |
Adenoma A benign epithelial tumor with a glandular organization. | 0 | 9.55 | 9 | 0 |
Adenoma, Adrenal Cortical [description not available] | 0 | 2.21 | 1 | 0 |
Adrenal Cortex Cancer [description not available] | 0 | 2.43 | 2 | 0 |
Adrenal Cortex Neoplasms Tumors or cancers of the ADRENAL CORTEX. | 0 | 2.43 | 2 | 0 |
Blood Pressure, High [description not available] | 0 | 5.71 | 12 | 0 |
Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. | 0 | 5.71 | 12 | 0 |
Hypertension, Essential [description not available] | 0 | 2.08 | 1 | 0 |
Adrenal Cancer [description not available] | 0 | 3.86 | 4 | 0 |
Essential Hypertension Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500 | 0 | 2.08 | 1 | 0 |
Congenital Adrenal Hyperplasia [description not available] | 0 | 2.02 | 1 | 0 |
Adrenal Hyperplasia, Congenital A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders. | 0 | 2.02 | 1 | 0 |
Adrenocorticotropic Hormone, Inappropriate Secretion [description not available] | 0 | 2.94 | 1 | 0 |
Cushing's Syndrome [description not available] | 0 | 8.33 | 2 | 0 |
Ectopic ACTH Syndrome [description not available] | 0 | 2.94 | 1 | 0 |
Adrenal Gland Hyperfunction [description not available] | 0 | 2.94 | 1 | 0 |
Adrenal Cortex Diseases Pathological processes of the ADRENAL CORTEX. | 0 | 3.35 | 2 | 0 |
ACTH Syndrome, Ectopic Symptom complex due to ACTH production by non-pituitary neoplasms. | 0 | 2.94 | 1 | 0 |
Adrenocortical Hyperfunction Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM. | 0 | 2.94 | 1 | 0 |
Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. | 0 | 3.33 | 2 | 0 |
Pituitary ACTH Hypersecretion A disease of the PITUITARY GLAND characterized by the excess amount of ADRENOCORTICOTROPIC HORMONE secreted. This leads to hypersecretion of cortisol (HYDROCORTISONE) by the ADRENAL GLANDS resulting in CUSHING SYNDROME. | 0 | 2.94 | 1 | 0 |
Experimental Hepatoma [description not available] | 0 | 1.96 | 1 | 0 |
Familial Hyperpotassemia and Hypertension [description not available] | 0 | 1.98 | 1 | 0 |
Pseudohypoaldosteronism A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION. | 0 | 1.98 | 1 | 0 |
Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. | 0 | 6.98 | 1 | 0 |
Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. | 0 | 3.31 | 2 | 0 |
Complications, Pregnancy [description not available] | 0 | 2.01 | 1 | 0 |
Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. | 0 | 2.01 | 1 | 0 |
Symptom Cluster [description not available] | 0 | 2.89 | 1 | 0 |
Syndrome A characteristic symptom complex. | 0 | 2.89 | 1 | 0 |